7 Our objective was to examine rates of reported myocarditis or pericarditis following mRNA vaccination by age, sex, vaccine product, dose number, interdose interval, and homologous (first and second doses with the same vaccine) or heterologous vaccine schedule using passive vaccine-safety ...